Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4289336 | 0.88 | CNR2 (0.42) | CNR2FFAR1ALDH1A1LMNAHTT | |
| SCHEMBL4282622 | 0.85 | L3MBTL1 (0.47) | CNR2L3MBTL1CNR1RXRARXRB | |
| SCHEMBL4294561 | 0.82 | LMNA (0.42) | L3MBTL1HDAC1TSHRALDH1A1MAPK1 | |
| SCHEMBL4285318 | 0.78 | RXRA (0.38) | L3MBTL1RXRARXRBFFAR1ALDH1A1 | |
| SCHEMBL5395059 | 0.74 | ALDH1A1 (0.41) | CNR2L3MBTL1TSHRALDH1A1MAPK1 | |
| SCHEMBL4285582 | 0.73 | CNR2 (0.44) | CNR2L3MBTL1CNR1TSHRFFAR1 | |
| SCHEMBL15132082 | 0.70 | L3MBTL1 (0.55) | CNR2L3MBTL1CNR1TSHRALDH1A1 | |
| SCHEMBL4291107 | 0.70 | CYP1A2 (0.46) | CNR2L3MBTL1CNR1TSHRALDH1A1 | |
| SCHEMBL4289338 | 0.69 | LRRK2 (0.43) | RXRAFFAR1HPGDHTTMAPT | |
| SCHEMBL5377818 | 0.69 | TSHR (0.43) | L3MBTL1TSHRALDH1A1MAPK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-2048150-A1 | BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | SLC5A1, SLC5A2, SLC2A1 | CNR2 991/4885L3MBTL1 2087/4885CNR1 661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.